DUBLIN and BARCELONA, Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as ...

This survey suggests that implanting a CRT-P or a CRT-D device is associated with broadly similar impact on symptoms and rates of hospitalization and survival as observed in landmark RCTs of patients ...

Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.

Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...

Please provide your email address to receive an email when new articles are posted on . The use of cardiac resynchronization therapy devices and implantable cardioverter defibrillators was associated ...

New York, NY and Oxford, UK - Whether by region in the US or by country in Europe, there is wide variation in the likelihood that an eligible patient with heart failure will receive a biventricular ...

Allure Quadra(TM) CRT-P (Photo: St. Jude Medical, Inc.) "Adding quadripolar technology to the CRT-P platform moves us forward in the treatment of heart failure and allows us to expand the proven ...

In a tight vote Tuesday, a U.S. Food and Drug Administration Circulatory Systems Device Advisory Panel recommended Medtronic‘s (MDT) CRT devices are beneficial for biventricular pacing when treating ...

It seems like not that long ago Medtronic was building the world's smallest pacemaker, the Micra, which represented a major leap in pacemaker technology. But Medtronic is not the type of company to ...

Medtronic has begun shipping its Consulta and Syncra cardiac resynchronization therapy-pacemaker (CRT-P) systems now that the FDA given its blessing for the products. Consulta is the first CRT-P that ...